The market was shocked last week to find out that Canopy Growth (CGC) hasn't been able to scale up cannabis-infused beverage production. So far, the market has generally ignored this huge flaw in the business built from the deal with Constellation Brands (STZ). The hopes were for the new CEO to streamline operations and cut money-losing divisions, but the initial work is even worse, requiring the executive to fix failed launches. My negative investment thesis is further reinforced here.
Image Source: BC Cannabis Stores website
Commercial Flaws
On January